BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12683744)

  • 1. Transient kinetic approach to the study of acetylcholinesterase reversible inhibition by eseroline.
    Golicnik M; Stojan J
    J Enzyme Inhib Med Chem; 2002 Oct; 17(5):279-85. PubMed ID: 12683744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic characterization of all steps of the interaction between acetylcholinesterase and eserine.
    Stojan J; Zorko M
    Biochim Biophys Acta; 1997 Jan; 1337(1):75-84. PubMed ID: 9003439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible inhibition of acetylcholinesterase by eseroline, an opioid agonist structurally related to physostigmine (eserine) and morphine.
    Galli A; Renzi G; Grazzini E; Bartolini R; Aiello-Malmberg P; Bartolini A
    Biochem Pharmacol; 1982 Apr; 31(7):1233-8. PubMed ID: 7092918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro and in-vivo protection of acetylcholinesterase by eseroline against inactivation by diisopropyl fluorophosphate and carbamates.
    Galli A; Malmberg Aiello P; Renzi G; Bartolini A
    J Pharm Pharmacol; 1985 Jan; 37(1):42-8. PubMed ID: 2858526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of rate constants for the irreversible inhibition of acetylcholine esterase by continuously monitoring the substrate reaction in the presence of the inhibitor.
    Liu W; Tsou CL
    Biochim Biophys Acta; 1986 Mar; 870(2):185-90. PubMed ID: 3955054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow detection reaction can mimic initial inhibition of an enzymic reaction.
    Stojan J
    J Enzyme Inhib; 2001; 16(2):89-94. PubMed ID: 11342277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylcholinesterase inhibition by eserine: rate constants of reaction. Part II.
    Brufani M; Lippa S; Marta M; Oradei A; Pomponi M
    Ital J Biochem; 1985; 34(5):328-40. PubMed ID: 4077467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of acetylcholinesterase from electric eel by (-)-and (+)-physostigmine and related compounds.
    Brossi A; Schönenberger B; Clark OE; Ray R
    FEBS Lett; 1986 Jun; 201(2):190-2. PubMed ID: 3709808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid-like action of eseroline on micturition reflex in rats.
    Maggi CA; Giuliani S; Patacchini R; Santicioli P; Conte B; Bartolini A; Meli A
    Gen Pharmacol; 1989; 20(1):17-22. PubMed ID: 2565272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new simple method for determining the kinetic constants of inhibited acetylcholinesterase.
    Brufani M; Lippa S; Littarru GP; Oradei A; Pomponi M
    Ital J Biochem; 1984; 33(5):325-32. PubMed ID: 6511307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A putative kinetic model for substrate metabolisation by Drosophila acetylcholinesterase.
    Stojan J; Marcel V; Estrada-Mondaca S; Klaebe A; Masson P; Fournier D
    FEBS Lett; 1998 Nov; 440(1-2):85-8. PubMed ID: 9862431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbamate analogues of (-)-physostigmine: in vitro inhibition of acetyl- and butyrylcholinesterase.
    Yu QS; Atack JR; Rapoport SI; Brossi A
    FEBS Lett; 1988 Jul; 234(1):127-30. PubMed ID: 3391264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular docking study on the "back door" hypothesis for product clearance in acetylcholinesterase.
    Alisaraie L; Fels G
    J Mol Model; 2006 Feb; 12(3):348-54. PubMed ID: 16341717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein ligand interactions. Part 5: Isoquinoline alkaloids as inhibitors of acetylcholinesterase from Electrophorus electricus.
    Whiteley CG; Daya S
    J Enzyme Inhib; 1995; 9(4):285-94. PubMed ID: 8598538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein ligand interactions 7 halogenated pyridinium salts as inhibitors of acetylcholinesterase from Electrophorus electricus.
    Whiteley CG; Ngwenya DS
    Biochem Mol Biol Int; 1995 Aug; 36(5):1107-16. PubMed ID: 7581006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate.
    Johnson JL; Cusack B; Davies MP; Fauq A; Rosenberry TL
    Biochemistry; 2003 May; 42(18):5438-52. PubMed ID: 12731886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect.
    Szegletes T; Mallender WD; Thomas PJ; Rosenberry TL
    Biochemistry; 1999 Jan; 38(1):122-33. PubMed ID: 9890890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein ligand interactions: alkylated pyridinium salts as inhibitors of acetylcholinesterase from Electrophorus electricus.
    Whiteley CG; Ngwenya DS
    Biochem Biophys Res Commun; 1995 Jun; 211(3):1083-90. PubMed ID: 7598696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors.
    Ariel N; Ordentlich A; Barak D; Bino T; Velan B; Shafferman A
    Biochem J; 1998 Oct; 335 ( Pt 1)(Pt 1):95-102. PubMed ID: 9742217
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.